Gotham Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Gotham Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-49,334	Closed	-$2.29M	–	1286
2019 Q2	$2.29M	Sell	49,334 -19,247	-28%	-$540K	0.04%	473
2019 Q1	$1.67M	Buy	68,581 +45,948	+203%	+$957K	0.02%	528
2018 Q4	$323K	Buy	+22,633	New	+$343K	0.01%	851
2016 Q4	–	Sell	-16,705	Closed	-$113K	–	1108
2016 Q3	$113K	Buy	+16,705	New	+$64.6K	﹤0.01%	897

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Gotham Asset Management's ARRY Position: Q3 2019 in Review

Gotham Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 49,334 shares — an estimated $2.29M sold.

Gotham Asset Management first reported a position in ARRY in Q3 2016 and held it in 4 quarters. The position peaked at $2.29M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Gotham Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Gotham Asset Management sold 49,334 Array Biopharma Inc shares in Q3 2019, an estimated $2.29M.
Gotham Asset Management first reported a position in Array Biopharma Inc in Q3 2016 and held it in 4 quarters.
Gotham Asset Management's Array Biopharma Inc position peaked at $2.29M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Gotham Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.